These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 24121879)

  • 21. Comparison of oncologic outcomes of metastatic rectal cancer patients with or without neoadjuvant chemoradiotherapy.
    Kim SH; Kim JH; Jung SH
    Int J Colorectal Dis; 2015 Sep; 30(9):1193-9. PubMed ID: 26072129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
    Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
    Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of resection of locally recurrent rectal cancer].
    Billiet C; Berard P; Rivoalan F; Neyra P; Gouillat C
    Ann Chir; 2006 Dec; 131(10):601-7. PubMed ID: 17010929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies.
    Belluco C; De Paoli A; Canzonieri V; Sigon R; Fornasarig M; Buonadonna A; Boz G; Innocente R; Perin T; Cossaro M; Polesel J; De Marchi F
    Ann Surg Oncol; 2011 Dec; 18(13):3686-93. PubMed ID: 21691880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curative potential of multimodality therapy for locally recurrent rectal cancer.
    Hahnloser D; Nelson H; Gunderson LL; Hassan I; Haddock MG; O'Connell MJ; Cha S; Sargent DJ; Horgan A
    Ann Surg; 2003 Apr; 237(4):502-8. PubMed ID: 12677146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilization of interventional radiology in the postoperative management of patients after surgery for locally advanced and recurrent rectal cancer.
    Llaguna OH; Calvo BF; Stitzenberg KB; Deal AM; Burke CT; Dixon RG; Stavas JM; Meyers MO
    Am Surg; 2011 Aug; 77(8):1086-90. PubMed ID: 21944529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?
    Rombouts AJ; Koh CE; Young JM; Masya L; Roberts R; De-Loyde K; de Wilt JH; Solomon MJ
    Dis Colon Rectum; 2015 Jan; 58(1):65-73. PubMed ID: 25489696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
    Madbouly KM; Hussein AM; Abdelzaher E
    Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical outcomes after total mesorectal excision for rectal cancer.
    Chiappa A; Biffi R; Bertani E; Zbar AP; Pace U; Crotti C; Biella F; Viale G; Orecchia R; Pruneri G; Poldi D; Andreoni B
    J Surg Oncol; 2006 Sep; 94(3):182-93; discussion 181. PubMed ID: 16900534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
    Kapiteijn E; Putter H; van de Velde CJ;
    Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.
    Lai IL; You JF; Chern YJ; Tsai WS; Chiang JM; Hsieh PS; Hung HY; Yeh CY; Chiang SF; Lai CC; Tang RP; Chen JS; Hsu YJ
    World J Surg Oncol; 2019 Dec; 17(1):212. PubMed ID: 31818295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
    Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
    Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage surgery for locally recurrent rectal cancer: total mesorectal excision during the primary operation does not influence the outcome.
    Wiig JN; Larsen SG; Dueland S; Flatmark K; Giercksky KE
    Colorectal Dis; 2011 May; 13(5):506-11. PubMed ID: 20236148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
    Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
    Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body mass index does not affect postoperative morbidity and oncologic outcomes of total mesorectal excision for rectal adenocarcinoma.
    Ballian N; Yamane B; Leverson G; Harms B; Heise CP; Foley EF; Kennedy GD
    Ann Surg Oncol; 2010 Jun; 17(6):1606-13. PubMed ID: 20077020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer.
    Frasson M; Garcia-Granero E; Roda D; Flor-Lorente B; Roselló S; Esclapez P; Faus C; Navarro S; Campos S; Cervantes A
    Cancer; 2011 Jul; 117(14):3118-25. PubMed ID: 21264832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A short course of preoperative radiotherapy improves prognosis of operable rectal carcinoma: a case control study.
    Penopoulos V; Handolias M; Avgerinos A; Maris T; Ilias T; Issopoulos N; Christianopoulos G; Betsis D; Vrettou E; Kitis G; Pistevou K
    Hepatogastroenterology; 2008; 55(85):1280-7. PubMed ID: 18795673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.